DISC MEDICINE INC (IRON)
US2546041011 - Common Stock
We assign a fundamental rating of 3 out of 10 to IRON. IRON was compared to 561 industry peers in the Biotechnology industry. IRON has a great financial health rating, but its profitability evaluates not so good. IRON does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
IRON had negative earnings in the past year.
In the past year IRON has reported a negative cash flow from operations.
IRON had negative earnings in each of the past 5 years.
IRON had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of IRON (-20.90%) is better than 76.22% of its industry peers.
IRON's Return On Equity of -22.11% is amongst the best of the industry. IRON outperforms 83.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.9% | ||
| ROE | -22.11% | ||
| ROIC | N/A |
ROA(3y)-31.78%
ROA(5y)N/A
ROE(3y)-35.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Profit Margin and Operating Margin and Gross Margin are not available for IRON so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The number of shares outstanding for IRON remains at a similar level compared to 1 year ago.
There is no outstanding debt for IRON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 41.46 indicates that IRON is not in any danger for bankruptcy at the moment.
IRON's Altman-Z score of 41.46 is amongst the best of the industry. IRON outperforms 96.94% of its industry peers.
IRON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 41.46 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
IRON has a Current Ratio of 19.36. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.
IRON's Current ratio of 19.36 is amongst the best of the industry. IRON outperforms 94.95% of its industry peers.
IRON has a Quick Ratio of 19.36. This indicates that IRON is financially healthy and has no problem in meeting its short term obligations.
IRON has a better Quick ratio (19.36) than 94.95% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 19.36 | ||
| Quick Ratio | 19.36 |
3. Growth
3.1 Past
The earnings per share for IRON have decreased by -4.55% in the last year.
EPS 1Y (TTM)-4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
IRON is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.30% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-22.86%
EPS Next 2Y-23.21%
EPS Next 3Y-17.45%
EPS Next 5Y9.3%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for IRON. In the last year negative earnings were reported.
Also next year IRON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
IRON's earnings are expected to decrease with -17.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.21%
EPS Next 3Y-17.45%
5. Dividend
5.1 Amount
No dividends for IRON!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
DISC MEDICINE INC
NASDAQ:IRON (1/6/2025, 4:30:02 PM)
After market: 62.04 0 (0%)62.04
-1.78 (-2.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners81%
Inst Owner Change0%
Ins Owners0.5%
Ins Owner Change0.16%
Market Cap1.85B
Analysts85.88
Price Target95.42 (53.8%)
Short Float %7.61%
Short Ratio5.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.14%
Min EPS beat(2)9.14%
Max EPS beat(2)17.14%
EPS beat(4)2
Avg EPS beat(4)1.47%
Min EPS beat(4)-13.49%
Max EPS beat(4)17.14%
EPS beat(8)4
Avg EPS beat(8)-10%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.48%
PT rev (3m)41.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.52%
EPS NY rev (1m)-0.07%
EPS NY rev (3m)8.59%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.95 | ||
| P/tB | 3.95 | ||
| EV/EBITDA | N/A |
EPS(TTM)-3.91
EYN/A
EPS(NY)-5.19
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-2.83
OCFYN/A
SpS0
BVpS15.72
TBVpS15.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -20.9% | ||
| ROE | -22.11% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-31.78%
ROA(5y)N/A
ROE(3y)-35.42%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 32.93% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 19.36 | ||
| Quick Ratio | 19.36 | ||
| Altman-Z | 41.46 |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)95.37%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.45%
EPS Next Y-22.86%
EPS Next 2Y-23.21%
EPS Next 3Y-17.45%
EPS Next 5Y9.3%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-50.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-59.15%
EBIT Next 3Y-16.18%
EBIT Next 5YN/A
FCF growth 1Y-97.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.9%
OCF growth 3YN/A
OCF growth 5YN/A